Chromosome 6p22 [cancer susceptibility candidate 15 (CASC15)] was recently defined as a neuroblastoma susceptibility locus (Russell et al., 2015) and the chromosome 6p22.3 CASC15 long intergenic non‐coding RNA (lincRNA locus) was discovered to be able to gain a genomic segment in melanoma (Lessard et al., 2015). The gene discussed is CASC15; the disease is melanoma.